Status:
COMPLETED
Study Comparing In-laboratory Polysomnography Electrocardiogram (PSG ECG) to Simultaneously Recorded In-laboratory ECG on the CPC M1 Device
Lead Sponsor:
National Jewish Health
Collaborating Sponsors:
MyCardio
Conditions:
Sleep Disorder
Eligibility:
All Genders
18-70 years
Phase:
NA
Brief Summary
Research study that will test a portable device (CPC M1) that records: body movement; heart activity (ECG; snoring; and body position during sleep. The Food and Drug Administration (FDA) has not appro...
Eligibility Criteria
Inclusion
- Adults (males and females) 18 to 70 years of age with a suspected sleep disorder.
- Subjects or legal guardians are able to verbalize an understanding of the consent form, provide written informed consent, and verbalize willingness to complete study procedures.
- Adequate dexterity to apply and remove the CPC M1 device.
Exclusion
- Patients with atrial fibrillation and ventricular tachycardia.
- Patients with an inability to apply the CPC M1 device.
- Pregnancy.
Key Trial Info
Start Date :
March 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2010
Estimated Enrollment :
50 Patients enrolled
Trial Details
Trial ID
NCT01234077
Start Date
March 1 2010
End Date
September 1 2010
Last Update
January 19 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
National Jewish Health
Denver, Colorado, United States, 80206